Skip to content

The Effect of Cerclage Pacing for the Heart Failure Patients Who Need Cardiac Resynchronization Therapy (CRT)

The Effect of Cerclage Pacing for the Heart Failure Patients Who Need Cardiac Resynchronization Therapy (CRT): Early Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03438591
Acronym
Cerclage-CRT
Enrollment
2
Registered
2018-02-19
Start date
2018-03-05
Completion date
2019-06-30
Last updated
2019-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, LBBB Complete

Keywords

cerclage pacing, cerclage-CRT, wide QRS

Brief summary

trans-coronary sinus intraseptal pacing (cerclage pacing)

Detailed description

This study is aimed at looking at the effect of Cerclage pacing for the heart failure patients who need cardiac resynchronization therapy (CRT). The study hypothesis is that parahisian pacing by 'cerclage pacing' may have a similar benefit as is seen with permanent Hisian pacing

Interventions

DEVICEMedtronic 4196 lead

Cerclage-CRT pacing with Medtronic 4196 lead (Attain Ability Lead)

Sponsors

Tau-MEDICAL Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

patients who meet the criteria of current CRT treatment

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* who need cardiac resynchronization therapy (CRT) or CRT-non responder * Left bundle branch block \[LBBB\]) \> 120ms of QRS width * Ejection fraction (EF) \< 35% * NYHA class III-IV in spite of optimal medical Tx

Exclusion criteria

* Unsuitable coronary vein anatomy on cardiac CT * Subjects with prosthetic mechanical tricuspid valve * Active infection * Life expectancy less than 6 months

Design outcomes

Primary

MeasureTime frameDescription
rate of procedural successimmediate postprocedureNarrowing QRS by 20% or greater compared with baseline QRS width

Secondary

MeasureTime frameDescription
Change in subjects' symptoms referred to NYHA Classification System12 monthsNYHA (New York Heart Association) : +1 grade
Change in subjects' improvement of parameters by Echocardiography12 monthsEjection Fraction +5%
Change of Six minute walk Distance12 monthsimprovement of SMWD
interrogation index of pacemaker lead12 monthsinterrogation index of pacemaker lead

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026